Interventional Glaucoma

Knowledge of tools used in data interpretation helps clinicians trust accuracy of findings.

Measurements from multiple studies show benefits of rho-kinase inhibition.

Increased access is key to preventing disease progression in patients.

Implandata received FDA Breakthrough Device Designation for its Eyemate-SC in April and now has CE Mark approval in the European Union.

Visible-light optical coherence tomography proves valuable in studies.

Details enhance knowledge of biological pathways that contribute to disease pathogenesis.

Physicians are left to determine which treatments can offer patients best outcomes.

Retrospective review highlights the sustained efficacy of combination procedure.

Option could prove to enhance safety for both patients and staff.

Use of such procedures increased markedly in analysis of IRIS Registry Data.

Oluwatosin U. Smith, MD, Glaucoma Associates of Texas, offers an update on optimization and surgical modifications of newer glaucoma surgeries in preop and postop settings.

Virtual reality, home visual field testing offer new options for physicians.

Investigators determine that patient rates of adherence with gonioscopy are low.

Ophthalmologists and industry KOLs share what lingers on their minds at the end of the day.

Michael A. Singer, MD, speaks on the highlights of his presentation focusing on IOP in the PALADIN 24-month data intravitreal steroid (ILUVIEN).

Ophthalmologist details his preferred technique to avoid complications during procedure.

Short learning curve, significant clinical advantages make this a comfortable addition.

IOP-controlling protein in the trabecular meshwork may get the fluid moving.

Approach can unravel causes in MYOC and TBK1 glaucoma.

Investigators find treatment is an option for treating open-angle glaucoma.

George Waring IV, MD serves as guest host for ‘History and Evolution of Contemporary Refractive Surgery’

Ophthalmologists share the most pressing issues on their mind within the glaucoma space — and why losing sleep from time to time may actually be a good thing.

A supraciliary minimally invasive glaucoma procedure may offer a valuable bleb-free treatment option for patients with glaucoma that requires low target pressures.

Physician presents pearls for effective use, leading to positive outcomes for patients.